Add to ORKGA method of treating a disorder related to a high cholesterol concentration, comprising administering to a subject in need thereof a compound of formula (I): Also disclosed are methods, kits, combinations, and compositions for treating a disorder in a subject where an activator of liver X alpha is indicated, such as in, for example, treating a high cholesterol disease
In this review article an analysis of literature data on the pharmacological and clinical study of a...
A method of modulating cytokine mediated hepatic injury by administering compound-D SEQ ID NO:1 to a...
The overloading of cholesterol in the arteries remains the principal cause of cardiovascular disease...
A method of treating a disorder related to a high cholesterol concentration, comprising administerin...
A method of treating a disorder related to a high cholesterol concentration, comprising administerin...
A method of treating a disorder related to a high cholesterol concentration, comprising administerin...
A compound is provided which comprises at least a portion of an amino acid linker-domain from squale...
Abstract: Cholesterol is transported around the body in the form of lipoprotein (lipid/protein) comp...
The present invention relates to compounds having pharmacological activity in the treatment of vascu...
An elevated low density lipoprotein cholesterol is a major cause of atherosclerosis. Reducing the co...
885-894The overloading of cholesterol in the arteries remains the principal cause of cardiovascular...
In light of a global rise in the number of patients with type 2 diabetes mellitus (T2DM) and obesity...
Several processes are involved in control of plasma cholesterol levels, e.g., intestinal cholesterol...
The present invention provides a formula and method for the prevention and treatment of hypercholest...
Compounds of formula (I): in which R1, R2, R3, R3′, R4, R5, R6, R6′, R7, R8, R9, R10, R11, R12, R13,...
In this review article an analysis of literature data on the pharmacological and clinical study of a...
A method of modulating cytokine mediated hepatic injury by administering compound-D SEQ ID NO:1 to a...
The overloading of cholesterol in the arteries remains the principal cause of cardiovascular disease...
A method of treating a disorder related to a high cholesterol concentration, comprising administerin...
A method of treating a disorder related to a high cholesterol concentration, comprising administerin...
A method of treating a disorder related to a high cholesterol concentration, comprising administerin...
A compound is provided which comprises at least a portion of an amino acid linker-domain from squale...
Abstract: Cholesterol is transported around the body in the form of lipoprotein (lipid/protein) comp...
The present invention relates to compounds having pharmacological activity in the treatment of vascu...
An elevated low density lipoprotein cholesterol is a major cause of atherosclerosis. Reducing the co...
885-894The overloading of cholesterol in the arteries remains the principal cause of cardiovascular...
In light of a global rise in the number of patients with type 2 diabetes mellitus (T2DM) and obesity...
Several processes are involved in control of plasma cholesterol levels, e.g., intestinal cholesterol...
The present invention provides a formula and method for the prevention and treatment of hypercholest...
Compounds of formula (I): in which R1, R2, R3, R3′, R4, R5, R6, R6′, R7, R8, R9, R10, R11, R12, R13,...
In this review article an analysis of literature data on the pharmacological and clinical study of a...
A method of modulating cytokine mediated hepatic injury by administering compound-D SEQ ID NO:1 to a...
The overloading of cholesterol in the arteries remains the principal cause of cardiovascular disease...